Skip to content

Norepinephrine

Catecholamine — CARDIOVASCULAR SYSTEM

Also known as: (-)-noradrenaline, (R)-Norepinephrine, arterenol, levarterenol, noradrenaline, norepinephrine bitartrate

OfpFDA approvedATC C01CA03

Data last refreshed: (DrugCentral release 2024-11-01)

Key facts

Norepinephrine is an ofp drug in the Catecholamine class catalogued in DrugCentral. It was first approved by the FDA in 1950. DrugCentral lists 27 molecular targets, including Adra2b|Adra2c|Adra2a, Adra1b|Adra2b|Adra2c|Adra2a|Adra1d|Adra1a and ADRA1D. Recorded indications include Acute exacerbation of asthma, Asthma, Asthma management and Bronchiectasis.

  • Approval status: ofp (first approved 1950 by the FDA).
  • Drug class: Catecholamine.
  • Molecular targets: Adra2b|Adra2c|Adra2a, Adra1b|Adra2b|Adra2c|Adra2a|Adra1d|Adra1a, ADRA1D and ADRA2C (27 listed in DrugCentral).
  • Indications: Acute exacerbation of asthma, Asthma, Asthma management, Bronchiectasis and Bronchitis and others.
  • ATC code: C01CA03 (Adrenergic and dopaminergic agents).
  • Molecular formula: C8H11NO3; molecular weight 169.18 g/mol.

Indications & contraindications

Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).

Indications (7)

  • Acute exacerbation of asthma
  • Asthma
  • Asthma management
  • Bronchiectasis
  • Bronchitis
  • Low blood pressure
  • Pulmonary emphysema

Contraindications (6)

  • Hypercapnia
  • Hypertensive disorder
  • Hypovolemia
  • Hypoxia
  • Occlusive Vascular Disease
  • Thrombosis

Mechanism & targets

Established pharmacologic classCatecholamine

Molecular targets (27)

TargetGeneActionActivity
Adrenergic receptor alpha-2Adra2b|Adra2c|Adra2aunknownKi 8.32
Adrenergic receptor alphaAdra1b|Adra2b|Adra2c|Adra2a|Adra1d|Adra1aunknownIC50 7.80
Alpha-1D adrenergic receptorADRA1DagonistKi 7.40
Alpha-2C adrenergic receptorADRA2CagonistKi 7.20
Alpha-2A adrenergic receptorADRA2AagonistKi 7.18
Alpha-2B adrenergic receptorAdra2bunknownKi 7.11
Beta-1 adrenergic receptorAdrb1unknownKi 6.90
Alpha-1B adrenergic receptorADRA1BunknownKi 6.58
Alpha-2B adrenergic receptorADRA2BunknownKi 6.48
Adrenergic receptor alpha-1Adra1b|Adra1d|Adra1aunknownKi 6.41
Beta-1 adrenergic receptorADRB1unknownKi 6.40
Alpha-1A adrenergic receptorADRA1AunknownKi 6.35
Alpha-2C adrenergic receptorAdra2cunknownKi 6.19
Adrenergic receptor betaAdrb2|Adrb1|Adrb3unknownIC50 6.00
Beta-1 adrenergic receptorADRB1agonistKi 6.00
D(2) dopamine receptorDRD2unknownKi 5.89
Alpha-1A adrenergic receptorADRA1AagonistKi 5.82
Beta-2 adrenergic receptorADRB2agonistKd 5.40
Beta-2 adrenergic receptorAdrb2unknownKi 5.38
Beta-3 adrenergic receptorADRB3unknownKi 5.37

Regulatory approvals (1)

DateAgencyMarketed asApplicantOrphan
1950-07-13FDA—HOSPIRA

ATC classification

ATC codeTherapeutic hierarchy
C01CA03CARDIOVASCULAR SYSTEM › CARDIAC THERAPY › CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES › Adrenergic and dopaminergic agents

Reported adverse-event signals

Strongest FDA FAERS disproportionality signals (log-likelihood ratio). A signal is a statistical association in spontaneous reports, not proof that the drug causes the event.

MedDRA termLLR
Multiple organ dysfunction syndrome1518.3
Drug ineffective1165.6
Cardiogenic shock1009.1
Appendicolith659.3
Cardiac arrest634.0
Septic shock622.8
Shock528.0
Ventricular fibrillation511.0
Appendicitis500.0
Hypotension490.5
Acute kidney injury471.7
Metabolic acidosis455.8

Chemical structure

Molecular formulaC8H11NO3
Molecular weight169.18 g/mol
CAS number—
InChIKeySFLSHLFXELFNJZ-QMMMGPOBSA-N
PubChem CID439260
NC[C@H](O)C1=CC(O)=C(O)C=C1

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

What is Norepinephrine used for?

DrugCentral lists the following indications for Norepinephrine: Acute exacerbation of asthma, Asthma, Asthma management, Bronchiectasis, Bronchitis, Low blood pressure and Pulmonary emphysema.

How does Norepinephrine work?

Its molecular targets in DrugCentral include Adra2b|Adra2c|Adra2a, Adra1b|Adra2b|Adra2c|Adra2a|Adra1d|Adra1a, ADRA1D (agonist) and ADRA2C (agonist).

When was Norepinephrine first approved?

Norepinephrine was first approved by the FDA in 1950.

What drug class does Norepinephrine belong to?

Norepinephrine is in the Catecholamine class.

What is the chemical formula of Norepinephrine?

Norepinephrine has the molecular formula C8H11NO3 and a molecular weight of 169.18 g/mol.

Browse: all drugs starting with N · drug guides by category · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.

Quick facts

StatusOFP
First approval1950-07-13
AgencyFDA
Targets27
Indications7
FormulaC8H11NO3
DrugCentral ID1960
Interactive profile